Medicure Inc. (OTCMKTS:MCUJF) Short Interest Down 58.3% in July

Medicure Inc. (OTCMKTS:MCUJF) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 500 shares, a decline of 58.3% from the June 30th total of 1,200 shares. Based on an average trading volume of 400 shares, the short-interest ratio is presently 1.3 days.

Medicure Stock Performance

Shares of MCUJF stock remained flat at $0.74 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.01 and a quick ratio of 1.59. Medicure has a 1 year low of $0.68 and a 1 year high of $1.26. The company has a market cap of $7.73 million, a price-to-earnings ratio of -9.25 and a beta of 0.98. The stock’s 50-day simple moving average is $0.80 and its 200 day simple moving average is $0.83.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.